UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 82

Sortiert nach

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

Clinical cancer research, 2007-08, Vol.13 (15), p.4429-4434

2007

Volltextzugriff (PDF)

Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care

Journal of clinical oncology, 2006-02, Vol.24 (6), p.848-855

2006

Volltextzugriff (PDF)

Standardized synoptic cancer pathology reporting: A population-based approach

Journal of surgical oncology, 2009-06, Vol.99 (8), p.517-524

2009

Volltextzugriff (PDF)

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP)

Journal of pain and symptom management, 2012-04, Vol.43 (4), p.663-678

2012

Volltextzugriff (PDF)

Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions

Journal of clinical oncology, 2000-07, Vol.18 (13), p.2515-2521

2000

Volltextzugriff (PDF)

Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing Data

Journal of clinical oncology, 2003-05, Vol.21 (10), p.1944-1951

2003

Volltextzugriff (PDF)

Randomized Trial of a Patient Decision Aid for Choice of Surgical Treatment for Breast Cancer

Medical decision making, 2001-01, Vol.21 (1), p.1-6

2001

Volltextzugriff (PDF)

Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series

Breast cancer research and treatment, 2009-03, Vol.114 (1), p.169-178

2009

Volltextzugriff (PDF)

Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen

Journal of clinical oncology, 2002-12, Vol.20 (24), p.4649-4654

2002

Volltextzugriff (PDF)

Lack of prognostic value of FCGR3A-V158F polymorphism in non-Hodgkin's lymphoma

Haematologica (Roma), 2008-08, Vol.93 (8), p.1265-1267

2008

Volltextzugriff (PDF)

Standardized synoptic cancer pathology reports - so what and who cares? A population-based satisfaction survey of 970 pathologists, surgeons, and oncologists

Archives of pathology & laboratory medicine (1976), 2013-11, Vol.137 (11), p.1599-1602

2013

Volltextzugriff (PDF)

Ontario, Canada: Using Networks to Integrate Palliative Care Province-Wide

Journal of pain and symptom management, 2007-05, Vol.33 (5), p.640-644

2007

Volltextzugriff (PDF)

Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening

Psycho-oncology (Chichester, England), 2012-04, Vol.21 (4), p.357-364

2012

Volltextzugriff (PDF)

Are medical oncologists biased in their treatment of the large woman with breast cancer?

Breast cancer research and treatment, 2001-03, Vol.66 (2), p.123-133

2001

Volltextzugriff (PDF)

Biological Significance of Occult Micrometastases in Histologically Negative Axillary Lymph Nodes in Breast Cancer Patients Using the Recent American Joint Committee on Cancer Breast Cancer Staging System

The breast journal, 2006-07, Vol.12 (4), p.294-301

2006

Volltextzugriff (PDF)

Prognostic factors affecting the natural history of node-negative breast cancer

Breast cancer research and treatment, 2005, Vol.89 (1), p.35-45

2005

Volltextzugriff (PDF)

Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer

Journal of surgical oncology, 2003-02, Vol.82 (2), p.84-90

2003

Volltextzugriff (PDF)

Primary care providers' experiences with and perceptions of personalized genomic medicine

Canadian family physician, 2016-10, Vol.62 (10), p.e626-e635

2016

Volltextzugriff (PDF)

Determining resource intensity weights in ambulatory chemotherapy related to nursing workload

Canadian oncology nursing journal, 2012, Vol.22 (2), p.114-120

2012

Volltextzugriff (PDF)

Déterminer la pondération de la consommation des ressources en chimiothérapie ambulatoire liée à la charge de travail des infirmières

Canadian oncology nursing journal, 2012-05, Vol.22 (2), p.121-128

2012

Volltextzugriff (PDF)

Clinician's Commentary

Physiotherapy Canada, 2010, Vol.62 (4), p.306-307

Sawka, Carol

2010

Volltextzugriff (PDF)

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women : A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

Breast cancer research and treatment, 1997-07, Vol.44 (3), p.211-215

1997

Volltextzugriff (PDF)

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

Breast cancer research and treatment, 1997-07, Vol.44 (3), p.201-210

1997

Volltextzugriff (PDF)

Quality oversight for specialized cancer services

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.103-103

2012

Volltextzugriff (PDF)

Using a disease pathway management (DPM) approach to improve the quality of lung cancer care in Ontario

Journal of clinical oncology, 2012-12, Vol.30 (34_suppl), p.93-93

2012

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(81)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care

Standardized synoptic cancer pathology reporting: A population-based approach

Quality Improvement in Cancer Symptom Assessment and Control: The Provincial Palliative Care Integration Project (PPCIP)

Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions

Quality of Life in a Randomized Trial of Group Psychosocial Support in Metastatic Breast Cancer: Overall Effects of the Intervention and an Exploration of Missing Data

Randomized Trial of a Patient Decision Aid for Choice of Surgical Treatment for Breast Cancer

Outcomes of surveillance mammography after treatment of primary breast cancer: a population-based case series

Randomized Phase III Study of Fludarabine Phosphate Versus Cyclophosphamide, Vincristine, and Prednisone in Patients With Recurrent Low-Grade Non-Hodgkin’s Lymphoma Previously Treated With an Alkylating Agent or Alkylator-Containing Regimen

Lack of prognostic value of FCGR3A-V158F polymorphism in non-Hodgkin's lymphoma

Standardized synoptic cancer pathology reports - so what and who cares? A population-based satisfaction survey of 970 pathologists, surgeons, and oncologists

Ontario, Canada: Using Networks to Integrate Palliative Care Province-Wide

Cancer Care Ontario's experience with implementation of routine physical and psychological symptom distress screening

Are medical oncologists biased in their treatment of the large woman with breast cancer?

Biological Significance of Occult Micrometastases in Histologically Negative Axillary Lymph Nodes in Breast Cancer Patients Using the Recent American Joint Committee on Cancer Breast Cancer Staging System

Prognostic factors affecting the natural history of node-negative breast cancer

Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer

Primary care providers' experiences with and perceptions of personalized genomic medicine

Determining resource intensity weights in ambulatory chemotherapy related to nursing workload

Déterminer la pondération de la consommation des ressources en chimiothérapie ambulatoire liée à la charge de travail des infirmières

Clinician's Commentary

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women : A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer

Quality oversight for specialized cancer services

Using a disease pathway management (DPM) approach to improve the quality of lung cancer care in Ontario

Suchergebnisse filtern